P. Marks

GHRH receptor-targeted botulinum neurotoxin selectively inhibits pulsatile GH secretion in male rats.

S. Lightman, J. Leggett, E. Harper, 2013, Endocrinology.

A botulinum toxin-derived targeted secretion inhibitor downregulates the GH/IGF1 axis.

P. Hüppi, S. Melmed, M. Aubert, 2012, The Journal of clinical investigation.

Crystal structure of a catalytically active, non-toxic endopeptidase derivative of Clostridium botulinum toxin A.

K. Acharya, N. Thiyagarajan, G. Masuyer, 2009, Biochemical and biophysical research communications.

Clostridial neurotoxins: structure-function led design of new therapeutics

J. Chaddock, P. Marks, P. Marks, 2006, Cellular and Molecular Life Sciences.

Preparation of specifically activatable endopeptidase derivatives of Clostridium botulinum toxins type A, B, and C and their applications.

Anthony Scott-Tucker, C. Shone, J. Chaddock, 2005, Protein expression and purification.